Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism.
Level 5 - mechanism / opinion, no new human data
Mechanism-based reasoning and theoretical model proposing a biochemical pathway without new clinical trial data.
PubMed 24558199 · doi:10.1096/fj.13-246546
What was done
The authors proposed a molecular and mechanistic framework evaluating how vitamin D hormone (calcitriol) regulates serotonin synthesis. They analyzed transcriptional regulation of tryptophan hydroxylase genes (TPH1 and TPH2) by vitamin D response elements (VDREs) and examined VDREs in oxytocin- and vasopressin-related genes to explain key characteristics of autism.
What was found
The abstract reports no numerical or clinical trial data. It describes a molecular mechanism wherein calcitriol activates transcription of central TPH2 at a VDRE and represses transcription of peripheral TPH1 at a distinct VDRE. Additionally, genes encoding oxytocin-neurophysin I preproprotein, the oxytocin receptor, and the arginine vasopressin receptor were reported to contain VDREs for activation.
Why it matters
The paper offers a mechanistic hypothesis linking vitamin D deficiency to low central and high peripheral serotonin levels in autism. This framework provides a biological rationale for exploring vitamin D and tryptophan supplementation in clinical research.
Limits
The paper presents a mechanistic hypothesis and narrative review rather than an empirical clinical trial. No patient sample, effect sizes, or quantitative outcome measures are reported in the abstract, and therapeutic claims remain unverified without controlled human trials.
Cited by
- supports Vitamin D helps regulate melatonin production in the body.